VIVX.F Share Price Performance
US$0.0001
0.00 (0.00%)
Price US$0.0001
Share PriceUS$0.0001
Avivagen Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
VIVX.F Community Narratives
There are no narratives available yet.
Recent VIVX.F News & Updates
No updates
Avivagen Inc. Key Details
Last Reported Earnings
Jul 31, 2023
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.06
- Gross Margin
- 42.70%
- Net Profit Margin
- -648.74%
- Debt/Equity Ratio
- -78.1%
Avivagen Inc. Competitors
Snowflake Analysis
About VIVX.F
- Founded
- 2005
- Employees
- n/a
- CEO
- WebsiteView website
Avivagen Inc. focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers OxC-beta Livestock, a premix for inclusion in livestock feeds; Vivamune health chews for dogs; Dr. Tobias dog chews; and Dr. Tobias Beta blend for the human immune system. It serves in Canada, Mexico, Brazil, the Philippines, Taiwan, and Thailand. Avivagen Inc. was incorporated in 2005 and is headquartered in Ottawa, Canada.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
Canadian Market Performance
- 7 Days: 1.1%
- 3 Months: 10.3%
- 1 Year: 22.1%
- Year to Date: 20.3%
Over the last 7 days, the market has risen 1.1%, driven by gains of 2.7% in the Materials sector. As for the past 12 months, the market is up 22%. Earnings are forecast to grow by 11% annually. Market details ›